DK0798971T3 - Forøgelse af creatin- og glycogenkoncentration i muskler - Google Patents

Forøgelse af creatin- og glycogenkoncentration i muskler

Info

Publication number
DK0798971T3
DK0798971T3 DK95940388T DK95940388T DK0798971T3 DK 0798971 T3 DK0798971 T3 DK 0798971T3 DK 95940388 T DK95940388 T DK 95940388T DK 95940388 T DK95940388 T DK 95940388T DK 0798971 T3 DK0798971 T3 DK 0798971T3
Authority
DK
Denmark
Prior art keywords
creatine
amount
increase
carbohydrate
retention
Prior art date
Application number
DK95940388T
Other languages
English (en)
Inventor
Paul Leonard Greenhaff
Allison Lesley Green
Ian Andrew Macdonald
Eric Hultman
Original Assignee
Univ Nottingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26306194&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0798971(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from GBGB9425514.8A external-priority patent/GB9425514D0/en
Application filed by Univ Nottingham filed Critical Univ Nottingham
Application granted granted Critical
Publication of DK0798971T3 publication Critical patent/DK0798971T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
DK95940388T 1994-12-17 1995-12-15 Forøgelse af creatin- og glycogenkoncentration i muskler DK0798971T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9425514.8A GB9425514D0 (en) 1994-12-17 1994-12-17 Retention of creatine in the body
GBGB9517443.9A GB9517443D0 (en) 1994-12-17 1995-08-25 Increasing creatine and glycogen concentration in muscle
PCT/GB1995/002933 WO1996018313A1 (en) 1994-12-17 1995-12-15 Increasing creatine and glycogen concentration in muscle

Publications (1)

Publication Number Publication Date
DK0798971T3 true DK0798971T3 (da) 2000-11-13

Family

ID=26306194

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95940388T DK0798971T3 (da) 1994-12-17 1995-12-15 Forøgelse af creatin- og glycogenkoncentration i muskler

Country Status (11)

Country Link
US (1) US5968900A (da)
EP (1) EP0798971B1 (da)
AT (1) ATE194462T1 (da)
AU (1) AU4185696A (da)
CA (1) CA2208047C (da)
DE (1) DE69518008T2 (da)
DK (1) DK0798971T3 (da)
ES (1) ES2150020T3 (da)
GB (1) GB9517443D0 (da)
PT (1) PT798971E (da)
WO (1) WO1996018313A1 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7150880B2 (en) * 1996-05-31 2006-12-19 The Original Creatine Patent Co. Ltd. Compositions containing creatine and creatinine and a methyl xanthine
US6080788A (en) * 1997-03-27 2000-06-27 Sole; Michael J. Composition for improvement of cellular nutrition and mitochondrial energetics
US6218366B1 (en) 1998-06-19 2001-04-17 Bioenergy, Inc. Method for raising the hypoxic threshold
US6159942A (en) * 1998-06-19 2000-12-12 Bioenergy, Inc. Compositions for increasing energy in vivo
US6429198B1 (en) 1999-04-12 2002-08-06 Bioenergy Inc. Compositions for increasing athletic performance in mammals
US20020119933A1 (en) 2000-07-28 2002-08-29 Butler Terri L. Compositions and methods for improving cardiovascular function
US6534480B2 (en) 1999-06-17 2003-03-18 Bioenergy Inc. Compositions for increasing energy in vivo
FR2797767B1 (fr) 1999-08-27 2002-06-14 Centre Nat Rech Scient Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances
GB9924650D0 (en) 1999-10-19 1999-12-22 Marathade Ltd Energy bar
US6703370B1 (en) 1999-10-27 2004-03-09 Bioenergy, Inc. Use of ribose to treat fibromyalgia
WO2001035953A2 (en) * 1999-11-17 2001-05-25 Kuhrts Eric H Exercise and muscle enhancement formulations
US6399661B1 (en) 2000-06-26 2002-06-04 Jeffrey M. Golini Oral creatine supplement and method for making same
US20030212134A1 (en) * 2001-04-16 2003-11-13 Dykstra John C. Combination of pinitol and creatine to enhance uptake and retention of creatine
US20030013767A1 (en) * 2001-07-13 2003-01-16 Samuel Bessman Method of treating weight loss using creatine
US20040013732A1 (en) * 2001-09-25 2004-01-22 Michael Farber Starch-based delivery system for creatine
US7067150B2 (en) 2002-04-16 2006-06-27 Scepter Holdings, Inc. Delivery systems for functional ingredients
US6903136B2 (en) * 2002-04-22 2005-06-07 Experimental And Applied Sciences, Inc. Food supplements containing 4-hydroxyisoleucine and creatine
WO2004069236A1 (ja) * 2003-02-06 2004-08-19 Otsuka Pharmaceutical Factory, Inc. 周術期血糖値上昇抑制剤
US7504118B2 (en) 2003-04-11 2009-03-17 Fhg Corporation Dietary supplements containing extracts of cinnamon and methods of using same to enhance creatine transport
NZ550929A (en) * 2004-05-07 2009-09-25 Thermo Formulations Ltd Nutritional composition for increasing creative uptake in skeletal muscle
CN101048179A (zh) * 2004-08-25 2007-10-03 Mtor配方设计公司 在骨骼肌中活化蛋白合成以及使分解代谢过程减活的组合物和方法
CA2642761A1 (en) * 2006-02-23 2007-08-30 Iomedix Sleep International Srl Compositions and methods for the induction and maintenance of quality sleep
US8613959B2 (en) * 2009-02-10 2013-12-24 Fhg Corporation Dietary supplements containing extracts of Nelumbo and processes of using same
US8703719B1 (en) 2009-05-18 2014-04-22 Bio-Engineered Supplements And Nutrition, Inc. Method and composition for improved muscle performance
US10674746B2 (en) 2015-10-27 2020-06-09 Cytozyme Animal Nutrition, Inc. Animal nutrition compositions and related methods
CN108473384A (zh) 2015-10-27 2018-08-31 细胞酶动物营养品公司 动物营养成分及相关方法
WO2017136143A1 (en) 2016-02-01 2017-08-10 Ribocor, Inc. Use of ribose for treatment of subjects having congestive heart failure

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1240336B (it) * 1990-03-21 1993-12-07 Setra Composizioni farmaceutiche,dietetiche o veterinarie ad attivita' eumetabolica
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot

Also Published As

Publication number Publication date
AU4185696A (en) 1996-07-03
ATE194462T1 (de) 2000-07-15
MX9704388A (es) 1998-07-31
EP0798971B1 (en) 2000-07-12
US5968900A (en) 1999-10-19
CA2208047A1 (en) 1996-06-20
EP0798971A1 (en) 1997-10-08
WO1996018313A1 (en) 1996-06-20
DE69518008T2 (de) 2001-05-17
CA2208047C (en) 2003-07-15
GB9517443D0 (en) 1995-10-25
PT798971E (pt) 2000-12-29
ES2150020T3 (es) 2000-11-16
DE69518008D1 (de) 2000-08-17

Similar Documents

Publication Publication Date Title
DK0798971T3 (da) Forøgelse af creatin- og glycogenkoncentration i muskler
DE2556100C2 (da)
US6645948B2 (en) Nutritional composition for the treatment of connective tissue
JPH04352718A (ja) 動物の肝臓のグリコーゲン貯蔵能力増大用治療剤
BR0109336A (pt) Medicamento para a prevenção, melhora e/ou tratamento de uma complicação diabética, droga medicinal adequada ou utilizável como o mesmo, método para prevenir, melhorar e/ou tratar a complicação diabética, e a neuropatia, e, usos de um agente redutor do açúcar no sangue pós-prandial e pelo menos um agente selecionado de um agente anti-hipertensivo, um agente vasodilatador e um agente anti-hiperlipidêmico
Gonce et al. Arginine supplementation and its effect on established peritonitis in guinea pigs
US6660308B1 (en) Beverage and additive for the ill
NO20023684L (no) Pediatrisk formulering
EP0637239A4 (en) METHOD FOR PROMOTING NITROGEN RETENTION IN PEOPLE.
KR920000324A (ko) 필수 지방산 처리법
KR920702217A (ko) 말라리아 치료 조성물
KR940018089A (ko) 내부조직의 방사선 손상에 대한 예방 및 처치방법
JPH01287041A (ja) 徐放性製剤
KR880005933A (ko) 비타민 b6-함유 약제학적 제제
KR900007424A (ko) 세포보호성 약제로서의 n-아세틸글루코사민의 사용방법 및 그 조성물
Waymack et al. Nutritional support of the burned patient
León et al. Arginine supplementation improves histone and acute‐phase protein synthesis during gram‐negative sepsis in the rat
HK1068824A1 (en) Insulin for use in a dosage regime
KR920702225A (ko) 약학 조성물
KR940013503A (ko) 동맥경화증의 예방 또는 치료용 약제학적 조성물
JPS57126420A (en) Drug for digestive organ
EP0459377B1 (en) Use of E1 prostaglandin to cure male erectile inpotence
KR900007434A (ko) 시스타틴을 유효 성분으로하는 치료제
US6979458B1 (en) Beverage and additive for wellness
Drill Effect of Vitamin B1 and Vitamin B2 Complex on the Loss of Weight Produced in Rats by Experimental Hyperthyroidism